🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or prison.

Platform Response and Content Removal

According to TikTok, the platform has taken down violative content and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the service safe and investing in enhancing compliance measures.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, filled with photos of slimming results, positive reviews and step-by-step guides for preparing or administering at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The seller provided an guidebook and promised delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject users to possibly serious medical dangers”.